These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20698168)

  • 1. Future perspectives of personalized oncology.
    Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
    Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics-based nanomedicine: the future of personalized oncology.
    Rosenblum D; Peer D
    Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.
    Efferth T
    Planta Med; 2010 Aug; 76(11):1143-54. PubMed ID: 20486071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology as the driving force for personalized oncology.
    Oktay MH; Hui P
    Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.
    Chen C; Peng J; Sun SR; Peng CW; Li Y; Pang DW
    Nanomedicine (Lond); 2012 Mar; 7(3):411-28. PubMed ID: 22385199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.
    McDermott U; Settleman J
    J Clin Oncol; 2009 Nov; 27(33):5650-9. PubMed ID: 19858389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome variation and personalized cancer medicine.
    Hudson TJ
    J Intern Med; 2013 Nov; 274(5):440-50. PubMed ID: 23751076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine: marking a new epoch in cancer patient management.
    Diamandis M; White NM; Yousef GM
    Mol Cancer Res; 2010 Sep; 8(9):1175-87. PubMed ID: 20693306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and personalized medicine.
    Sadee W
    Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personalized medicine 2011].
    Blum HE
    Dtsch Med Wochenschr; 2011 Mar; 136(10):459-60. PubMed ID: 21365521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
    Lackner MR
    Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapies and personalized medicine in gynecologic malignancies.
    Schiavone MB; Bashir S; Herzog TJ
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):131-44. PubMed ID: 22640707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is tailored therapy feasible in oncology?
    Gasparini G; Longo R; Torino F; Gattuso D; Morabito A; Toffoli G
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):79-101. PubMed ID: 16337806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.